Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Oral CBD with/without THC
NCT04283019Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of cannabidiol (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Urine cannabinoid concentrations at Day 21. Started Aug 2021; status: completed.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on NCT04283019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04283019.